Most cited article - PubMed ID 17448293
Valproic acid, a molecular lead to multiple regulatory pathways
Spinal cord injury is a devastating medical condition with no effective treatment. One approach to SCI treatment may be provided by stem cells (SCs). Studies have mainly focused on the transplantation of exogenous SCs, but the induction of endogenous SCs has also been considered as an alternative. While the differentiation potential of neural stem cells in the brain neurogenic regions has been known for decades, there are ongoing debates regarding the multipotent differentiation potential of the ependymal cells of the central canal in the spinal cord (SCECs). Following spinal cord insult, SCECs start to proliferate and differentiate mostly into astrocytes and partly into oligodendrocytes, but not into neurons. However, there are several approaches concerning how to increase neurogenesis in the injured spinal cord, which are discussed in this review. The potential treatment approaches include drug administration, the reduction of neuroinflammation, neuromodulation with physical factors and in vivo reprogramming.
- Keywords
- astrocytes, ependymal stem cells, growth factors, neurogenesis, neuroinflammation, physical factors, reprogramming, spinal canal, spinal cord injury, valproic acid,
- MeSH
- Cell Differentiation MeSH
- Humans MeSH
- Spinal Cord MeSH
- Neural Stem Cells * MeSH
- Neurogenesis MeSH
- Neurons MeSH
- Spinal Cord Injuries * therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH